DSM Capital Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-649,112
Closed -$19.9M 70
2020
Q4
$19.9M Buy
+649,112
New +$19.8M 0.21% 27
2020
Q3
Sell
-1,164,187
Closed -$25M 48
2020
Q2
$25M Sell
1,164,187
-3,608,344
-76% -$79.7M 0.3% 28
2020
Q1
$107M Buy
4,772,531
+211,145
+5% +$5.78M 1.62% 20
2019
Q4
$134M Buy
4,561,386
+673,481
+17% +$18.3M 1.78% 22
2019
Q3
$103M Buy
3,887,905
+90,075
+2% +$2.7M 1.59% 25
2019
Q2
$128M Buy
3,797,830
+742,713
+24% +$24.1M 1.87% 18
2019
Q1
$98M Buy
+3,055,117
New +$94M 1.44% 23

Other funds holding ELAN

DSM Capital Partners's ELAN Position: Q1 2021 in Review

DSM Capital Partners sold out of Elanco Animal Health (ELAN) in Q1 2021, closing a stake of 649,112 shares — an estimated $19.9M sold.

DSM Capital Partners first reported a position in ELAN in Q1 2019 and held it in 7 quarters. The position peaked at $134M in Q4 2019. 450 funds tracked by Wall St. Rank hold ELAN as of Q1 2021.

  • DSM Capital Partners reported no remaining Elanco Animal Health position as of Q1 2021 after selling out during the quarter.
  • DSM Capital Partners sold 649,112 Elanco Animal Health shares in Q1 2021, an estimated $19.9M.
  • DSM Capital Partners first reported a position in Elanco Animal Health in Q1 2019 and held it in 7 quarters.
  • DSM Capital Partners's Elanco Animal Health position peaked at $134M in Q4 2019.
  • 450 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2021.

Based on DSM Capital Partners's 13F filing for Q1 2021, filed 14 May 2021.